| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1399-5448.2010.00741.X |
| P698 | PubMed publication ID | 21366813 |
| P50 | author | Marco Cappa | Q42640467 |
| Valerio Nobili | Q56507694 | ||
| P2093 | author name string | Claudia Brufani | |
| Danilo Fintini | |||
| Patrizia Ippolita Patera | |||
| Mario Brufani | |||
| P2860 | cites work | A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. | Q42652148 |
| Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. | Q42662677 | ||
| Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study | Q42966770 | ||
| Pubertal metformin therapy to reduce total, visceral, and hepatic adiposity | Q43272937 | ||
| Type 2 diabetes in children and adolescents | Q43276515 | ||
| The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes | Q43596715 | ||
| Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial | Q43843247 | ||
| Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance | Q43946855 | ||
| Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism | Q44238672 | ||
| Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial | Q44262745 | ||
| Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity | Q44599557 | ||
| Metformin for the treatment of the polycystic ovary syndrome | Q44934959 | ||
| Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species | Q44987425 | ||
| Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial | Q45841776 | ||
| Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. | Q45982676 | ||
| Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy. | Q46002148 | ||
| A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism | Q46066332 | ||
| Sexual dimorphism of body composition and insulin sensitivity across pubertal development in obese Caucasian subjects | Q46120269 | ||
| Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche. | Q46719157 | ||
| Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study | Q46989905 | ||
| Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin. | Q51500574 | ||
| Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. | Q51500597 | ||
| Long-Term Efficacy and Tolerability of Flutamide Combined with Oral Contraception in Moderate to Severe Hirsutism: A 12-Month, Double-Blind, Parallel Clinical Trial | Q57487571 | ||
| A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated With Initiation of Atypical Antipsychotic Therapy in Children and Adolescents | Q57812515 | ||
| Metformin: An Update | Q22241145 | ||
| Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes | Q22241283 | ||
| Toxic Effects from Metformin Exposure | Q22241557 | ||
| Metformin Treatment to Prevent Early Puberty in Girls with Precocious Pubarche | Q22241661 | ||
| Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 | ||
| Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review | Q22242709 | ||
| Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 | ||
| Metformin | Q22250907 | ||
| Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus | Q24240522 | ||
| Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents | Q24241119 | ||
| Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
| Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease | Q28275665 | ||
| Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. | Q33318337 | ||
| Treatment of nonalcoholic fatty liver disease in children: TONIC trial design | Q34114795 | ||
| Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). | Q34285382 | ||
| Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS). | Q34347608 | ||
| Management of atypical antipsychotic drug-induced weight gain: focus on metformin | Q34983478 | ||
| Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents | Q35101190 | ||
| Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women | Q36366167 | ||
| Treatment of PCOS in adolescence | Q36505913 | ||
| The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials | Q36971967 | ||
| Addition of metformin to a lifestyle modification program in adolescents with insulin resistance | Q36980289 | ||
| Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism | Q37251943 | ||
| Metformin for obesity in children and adolescents: a systematic review | Q37319254 | ||
| Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review | Q37341358 | ||
| Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes | Q37363550 | ||
| Update on nonautoimmune diabetes in children | Q37543775 | ||
| Pediatric nonalcoholic fatty liver disease in 2009. | Q37601653 | ||
| The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism | Q38289469 | ||
| Metformin for weight control in pediatric patients on atypical antipsychotic medication. | Q39971938 | ||
| Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women. | Q40433879 | ||
| P433 | issue | 6 | |
| P921 | main subject | metformin | Q19484 |
| P304 | page(s) | 580-588 | |
| P577 | publication date | 2011-03-03 | |
| P1433 | published in | Pediatric Diabetes | Q7159203 |
| P1476 | title | Use of metformin in pediatric age | |
| P478 | volume | 12 |
| Q47217653 | Brief Report: Metformin for Antipsychotic-Induced Weight Gain in Youth with Autism Spectrum Disorder |
| Q85744351 | Childhood obesity |
| Q93081796 | Evolving Pharmacotherapeutic Strategies for Type 1 Diabetes Mellitus |
| Q37354917 | Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods |
| Q35972244 | Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands. |
| Q58756822 | Long-term metformin treatment in adolescents with obesity and insulin resistance, results of an open label extension study |
| Q33712645 | No increase in new users of blood glucose-lowering drugs in Norway 2006-2011: a nationwide prescription database study |
| Q53144570 | Pharmacokinetics of metformin in girls aged 9 years. |
Search more.